Intraoperative Mitomycin C in Lacrimal Sac Mucocele

Evaluation of Intraoperative Mitomycin C in Surgical Management of Lacrimal Sac Mucocele

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03176355

Enrollment

Registered

2017-06-05

Start date

2011-03-23

Completion date

2013-01-07

Last updated

2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lacrimal Mucocele

Brief summary

30 patients had lacrimal sac mucocele and dacryocystorhinostomy was done for them with intraoperative mitomycin C was added to decrease postoperative fibrosis and recurrence.

Interventions

PROCEDURECanaliculo- Dacryocystorhinostomy

Bypass lacrimal passage obstruction by opening a shunt between the lacrimal sac and the nasal mucosa

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Lacrimal sac mucocele

Exclusion criteria

* Paediatric patients (less than 16 years old). * Previous lacrimal passage procedure. * Neoplasms as secondary causes of obstruction.

Design outcomes

Primary

Measure	Time frame	Description
Disappearance of the watering of the eye reported by the patients and by fluorescein disappearance test	1 month	Patency of the lacrimal passage
Disappearance of lacrimal sac swelling	1 month	No evident swelling in the medial side of the eye

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026